Biallelic Variants in the DARS2 Gene as a Novel Cause of Axonal Charcot–Marie–Tooth Disease
Annals of Neurology · 2025
DOI: 10.1002/ana.78005 ↗Kurz gefasst
Fachartikel in der Zeitschrift Annals of Neurology, 2025. Verfasst von Berta Estévez-Arias und 23 weiteren Autor:innen. Beteiligte Einrichtung: Neuromuscular Unit, Department of Neurology, Hospital Sant Joan de Déu, Barcelona, Spain. Hauptthemen laut MEDLINE: Charcot-Marie-Tooth Disease, Axons, Aspartate-tRNA Ligase. Die Arbeit nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Secretary of Universities and Research of the Department of Research and Universities, Instituto de Salud Carlos III, Spain, Spanish Research Agency (AEI).
Abstract (Originalsprache)
Objective
Charcot–Marie–Tooth (CMT) disease is a heterogeneous group of genetic neuropathies, with >90 genes identified. Several aminoacyl‐tRNA synthetases have been linked to CMT. DARS2 , encoding the mitochondrial aspartyl‐tRNA synthetase, has been typically associated with leukoencephalopathy with brainstem and spinal cord involvement and lactate elevation. This study aimed to investigate the association between biallelic DARS2 variants and axonal CMT.
Methods
We investigated 5 individuals from 3 unrelated families with axonal CMT and biallelic DARS2 variants. Functional studies in fibroblasts assessed their effects on DARS2 expression, localization, and mitochondrial function. Enzymatic activity was evaluated in HEK293 cells.
Results
The 5 individuals, including 4 adults, presented with childhood‐onset progressive axonal CMT. None had leukoencephalopathy, but one showed central nervous system involvement, with intellectual disability and epilepsy. Genetic analysis identified compound heterozygous DARS2 variants: family A, p.Ser238Phe and p.Arg336Cys; family B, p.Ser238Phe and p.Ile25Thrfs*38; family C, c.492+2T>C and p.Pro503Leu. Functional studies revealed reduced DARS2 protein levels, mitochondrial network abnormalities, and impaired mitochondrial function. p.Ser238Phe behaves as a hypomorphic allele, whereas p.Pro503Leu reduced DARS2 enzymatic activity by 75%.
Interpretation
Our findings expand the DARS2 ‐related disease spectrum, establishing a novel association with axonal CMT. Hypomorphic variants, such as p.Ser238Phe, when paired with more deleterious variants, result in isolated axonal CMT, whereas more severe combinations—although not as deleterious as those seen in leukoencephalopathy with brainstem and spinal cord involvement and lactate elevation—result in axonal CMT with central nervous system involvement, albeit without leukoencephalopathy. These observations raise the possibility that DARS2 ‐associated diseases form a continuum rather than representing strictly distinct central or peripheral nervous system disorders. ANN NEUROL 2025;98:1335–1351
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Neuromuscular Unit, Department of Neurology, Hospital Sant Joan de Déu, Barcelona, Spain.
- Laboratory of Neurogenetics and Molecular Medicine, Center for Genomic Sciences in Medicine, Institut de Recerca Sant Joan de Déu, Barcelona, Spain.
- Universitat de Barcelona (UB), Barcelona, Spain.
- Institute of Clinical Medicine, University of Tartu, Tartu, Estonia.
- Marseille Medical Genetics, Aix-Marseille University-Inserm UMR 1251, Marseille, France.
- Genetic Department, Timone Hospital, APHM, Marseille, France.
ORCID-Profile: Berta Estévez-Arias, Siiri Sarv, Nathalie Bonello-Palot, Carsten G Bönnemann, Janet Hoenicka, Daniel Natera-de Benito, Francesc Palau
Förderung
- Secretary of Universities and Research of the Department of Research and Universities
- Instituto de Salud Carlos III, Spain
- Spanish Research Agency (AEI)
- European Union's Horizon Europe
- AGAUR
- Generalitat de Catalunya
- Estonian Research Council
- Estonian Social Ministry
Zitieren
APA
Estévez-Arias, B., Sarv, S., Bonello-Palot, N., Carrera-García, L., Ortez, C., Expósito-Escudero, J., Yubero, D., Muchart, J., Delmont, E., Õiglane-Shlik, E., Meren, T., Puusepp, S., Murumets, Ü., Salomons, G. S., Udd, B., Väli, L., Cantarero, L., Bönnemann, C. G., Nascimento, A., …, & Palau, F. (2025). Biallelic Variants in the DARS2 Gene as a Novel Cause of Axonal Charcot–Marie–Tooth Disease. Annals of Neurology. https://doi.org/10.1002/ana.78005
Vancouver
Estévez-Arias B, Sarv S, Bonello-Palot N, Carrera-García L, Ortez C, Expósito-Escudero J, et al. Biallelic Variants in the DARS2 Gene as a Novel Cause of Axonal Charcot–Marie–Tooth Disease. Annals of Neurology. 2025. doi:10.1002/ana.78005
BibTeX
@article{EstvezArias2025,
author = {Estévez-Arias, Berta and Sarv, Siiri and Bonello-Palot, Nathalie and Carrera-García, Laura and Ortez, Carlos and Expósito-Escudero, Jesica and Yubero, Delia and Muchart, Jordi and Delmont, Emilien and Õiglane-Shlik, Eve and Meren, Teele and Puusepp, Sanna and Murumets, Ülle and Salomons, Gajja S and Udd, Bjarne and Väli, Liis and Cantarero, Lara and Bönnemann, Carsten G and Nascimento, Andrés and Ramón-Maiques, Santiago and Õunap, Katrin and Hoenicka, Janet and Natera-de Benito, Daniel and Palau, Francesc},
title = {Biallelic Variants in the DARS2 Gene as a Novel Cause of Axonal Charcot–Marie–Tooth Disease},
journal = {Annals of Neurology},
year = {2025},
doi = {10.1002/ana.78005}
}
EUVIMED